Scoop Up Cancer Cells for Analysis | GenomeWeb

Researchers at Massachusetts General Hospital have developed a microfluidics chip that captures rare cancer cells in numbers that are high enough to enable analysis for molecular markers, reports Technology Review's Emily Singer. The device could save patients the hassle and pain of tumor biopsies since a sufficient number of cells could be culled from the bloodstream, and doctors could pick better drugs for their patients by doing the molecular marker analysis, she adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.